In humans, the administration of Lactobacilli vaginal tablets significantly reduces interleukin-1β (IL-1β) and (interleukin-6) IL-6 secretion in bacterial vaginosis, testifying the modulatory effects of Lactobacilli on the vaginal inflammatory response [114]. Here, IL6 is linked to bacterial vaginosis.